|
Rational Affinity Devices, LLC (RAD) |
|
|
211 Warren Street Newark, NJ 07103 USA phone:732-470-6970 fax:973-643-4502
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
|
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| RAD delivers cost-effective, molecular solutions to life science customers. |
 |
| Management |
| Les Beading-President and CEO |
| |
|
|
| |
|
| Keywords |
| Molecular Solutions, Molecular and cellular purification |
|
|
|
| Description |
|
Rational Affinity Devices, LLC delivers cost-effective, molecular solutions to life science customers through rational design and development of patented, innovative, accurate and reliable methods for molecular and cellular purification, detection and analysis. RAD has now demonstrated utility of its platform technology in several applications, including purification of high-value antibodies for diagnostic and therapeutic use, ultra-sensitive detection and qualification of nuleic acids and proteins for research and diagnostic use, and high-content analysis of bacterial strains to address the growing public health problems resulting from the spread of antibiotic resistant organisms through hospital- and community-acquired infection. |
 |
 |
|
|
|
|
|
|